Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2009 13:07 ET | Source: Marshall Edwards, Inc.

Biotech Analyst Joins Board of Directors of Marshall Edwards, Inc.

NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - March 19, 2009) - Marshall Edwards, Inc. (NASDAQ: MSHL) is pleased to announce the appointment of Leah Cann to the Board of Directors of the...
October 30, 2008 19:19 ET | Source: Novogen, Limited

Marshall Edwards' Phenoxodiol and Novogen's NV-128 Display Divergent Mechanisms of Action but Potent Synergistic Anti-Cancer Activity When Used in Combination

NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - October 30, 2008) - Pre-clinical studies presented at the 9th International Conference on Membrane Redox Systems in Wellington New Zealand this...
April 13, 2008 16:00 ET | Source: Marshall Edwards, Inc.

Marshall Edwards, Inc.'s Investigational Drug Triphendiol (NV-196) Demonstrates Potent Activity Against Biliary Cancers

SAN DIEGO, CA--(Marketwire - April 13, 2008) - Pre-clinical studies presented here today at the annual meeting of the American Association for Cancer Research demonstrate that Marshall Edwards,...
March 10, 2008 08:00 ET | Source: Marshall Edwards, Inc.

Phenoxodiol Trials Highlighted at Ovarian Cancer Action International Conference

SYDNEY, AUSTRALIA and LONDON and NEW CANAAN, CT--(Marketwire - March 10, 2008) - The role of the investigational drug phenoxodiol in restoration of chemosensitivity in ovarian cancer patients...
February 19, 2008 07:31 ET | Source: Marshall Edwards, Inc.

Additional Orphan Drug Status Granted for Melanoma for Marshall Edwards' Investigational Anti-Cancer Drug Triphendiol (NV-196)

NEW CANAAN, CT--(Marketwire - February 19, 2008) - Marshall Edwards, Inc., (NASDAQ: MSHL) announced today that triphendiol (previously known as NV-196) has been granted Orphan Drug status by the U.S....
October 24, 2007 08:07 ET | Source: Novogen

Novogen NV-128 Induces Novel Mode of Cell Death in Cancer Cells

SAN FRANCISCO, CA--(Marketwire - October 24, 2007) - Laboratory studies presented late yesterday at the annual AACR/EORTC/NCI Molecular Targets and Cancer Therapeutics conference demonstrate that...